World Market for Prescription Generic Drugs, 6th Edition
Generics, so long the force that has shaken up the branded pharmaceutical industry, is now facing its own challenges as an industry. While growth indications are strong, there are challenges for generic companies. In the next two years, consolidation will most likely rise; the sector is expected to be rocked by increased competition from companies in Eastern Europe, India and China, as well as brand name companies seeking to protect their franchises by moving into generics.
Kalorama Information's World Market for Prescription Generic Drugs, 6th Edition is your guide to this formidable and important participant in the complex world of healthcare. Included are market size and forecast revnues for:
For each drug segment, the report provides:
- Estimated Generic Market Size
- Forecast to 2012
- Recent ANDA Approvals
- World and US Market Share
- Company Profiles
- Legislative Issues
- Big Pharma Tactics
- Authorized Generics
- Generic Biologics
- Medicaid Generic Drug Reimbursement
- The Elderly
- Confusion in Generic Names
- Broadening Generic Horizons
- International Generic Drug Issues
- Indian Drug Makers
- Industry Consolidation
- New Generic Giants
- Patent Issues
- Generic Companies Increasingly Aggressive
- Patent Reform
- Generic Growth
- Generic Statins
- Generics Improve Compliance
- Generic Drug Sampling
Marketing executives, business development managers and brand and generic pharmaceutical companies, consultants and investors are among those who will benefit from this report.
Search for an exact word or phrase by placing the word or phrase in quotation marks ("market trend"). Search for different versions or tenses of a word by placing an asterisk at the end of the word (pharma*).
Please note that your term must be at least three characters long and numbers will be blocked by the # sign.